Correlating Time-Lapse Parameters With aCGH Testing in IVF Treatment (aCGH Study)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-05-31

Study Completion Date

2016-02-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this research study protocol is to collect imaging data on embryos followed to blastocyst stage (Day 5-6) and correlate Eeva parameters with array - Comparative Genomic Hybridization (aCGH) results and ongoing pregnancy rates.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Correlating Time-Lapse Parameters Detected by the Eeva™ System With Comprehensive Chromosome Screening Results

NCT01635049

Infertility

COMPLETED

Eeva System Imaging Study

NCT02301637

Infertility

UNKNOWN

Eeva™ System Study: Noninvasive Recording and Visualization of Individual Embryos Cultured to Blastocyst Stage

NCT01369446

Infertility

COMPLETED

Registry Study of Traditional Morphology Grading Combined With Eeva in IVF Treatment

NCT01816802

Infertility

UNKNOWN

Next Generation Sequencing Screening for Embryonic Ploidy Status

NCT02032264

Infertility

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The present study was designed to determine if there is a correlation between the Eeva System parameters and aCGH testing results. Embryos will be selected for transfer based on aCGH results and morphology. The Clinical site will have no access to the Eeva analysis at the time of the transfer.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Infertility

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

IVF patients undergoing aCGH Testing

Women undergoing fresh IVF treatment and array-comparative genomic hybridization testing (aCGH), as recommended based on medical need by the clinical site reproductive endocrinologist.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subject is ≤43 years of age.
* Women undergoing IVF treatment with planned aCGH testing using her own eggs or donor eggs.
* Antral Follicle Count ≥ 6 at time of cycle start
* Baseline (day 2-3 of cycling) FSH ≤ 15 mIU/ml
* Antimüllerian Hormone level ≥ 0.5 ng/mL
* Fertilization using only ejaculated sperm (fresh or frozen) - no surgically retrieved sperm.
* Willing to have all 2PN embryos monitored by Eeva
* Not previously enrolled in this study.
* Willing to comply with study protocol and procedures and able to speak English.
* Willing to provide written informed consent.